PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ∞ AND METABOLIC DISEASE

Timothy Mark Willson, Millard H. Lambert, Steven A. Kliewer · 2001

■ Abstract The nuclear peroxisome proliferator‐activated receptor∞ (PPAR∞ )i s a transcription factor that is activated by polyunsaturated fatty acids and their metabolites and is essential for fat cell formation. Although obesity is a strong risk factor for type 2 diabetes mellitus and other metabolic diseases, potent PPAR∞ activators such as the glitazone drugs lower glucose and lipid levels in patients with type 2 diabetes and also have antiatherosclerotic and antihypertensive effects. We review recent studies providing insight into the paradoxical relationship between PPAR∞ and metabolic disease. We also review recent advances in understanding the structural basis for PPAR∞ activation by ligands. The unusual ligand-binding properties of PPAR∞ suggest that it will be possible to discover new chemical classes of receptor “modulators” with distinct pharmacological activities for the treatment of type 2 diabetes and other metabolic diseases.

Cited by 154 works.

Authors

References